1.
Almeida LFC de, Silva LFL da, Vieira ACP, Cappellaro AP, Batalini F. Metronomic versus standard fixed dosing chemotherapy in human epidermal growth factor receptor-type 2-negative metastatic breast cancer: a reconstructed individual patient data meta-analysis. MAST [Internet]. 2026 Feb. 24 [cited 2026 May 1];35(suppl.1). Available from: https://mastology.org/journal/article/view/1170